A clinical trial to study the effect of trial drug UPPU CHENDURAM II on Gunmam(Peptic Ulcer)

A prospective open Labeled randomized clinical trial on Eri Gunmam(Peptic Ulcer Disease )with evaluation of trial drug Uppu Chenduram-II

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009270

Enrollment

Registered

2017-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Uppu Chenduram II: 130 mg orally bid with warm water for 30 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient with appropriate symptoms of upper abdominal pain nausea waterbrash headache flatulence excessive sweating loss of body weight lack of food intake Patient who are willing to sign consent form and undergo laboratory investigations

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Haemetemesis Malena Pancreatitis Inflammatory bowel disease Hyertensive heart disease Chronic kidney disease

Design outcomes

Primary

Measure	Time frame
The therapeutic efficacy of trial drug Uppu Chenduram II on Eri GunmamTimepoint: 30 days	—

Secondary

Measure	Time frame
Evaluation of Siddha diagnostic parametersTimepoint: 30 days	—

Countries

India

Contacts

Public ContactG Subash chandran MD Siddha PhD

Government Siddha Medical college and hospital

siddhadrgs21@gmail.com9443358271

Outcome results